Azacitidine(Aza) to treat chronic myelomonocytic leukemia (CMML)

Ryota Imanaka

Presentation information

Poster Session

Sun. Oct, 14

Poster Session 3-14 MDS: Clinical (5)

Sun. Oct 14, 2018 1:00 PM - 1:40 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Tomoya Maeda (Department of Hemato-Oncology Saitama Medical University International Medical University International Medical Center)

[PS3-14-7] Azacitidine(Aza) to treat chronic myelomonocytic leukemia (CMML)

Ryota Imanaka¹, Hideki Asaoku¹, Tatsuji Mino¹, Takeshi Okatani¹, Kohei Kyo¹, Mitsuhiro Itagaki¹, Yuta Katayama¹, Shinya Katsutani¹, Koji Iwato², Taiichi Kyo³ (1.Div. Hematology, Hiroshima Red-Cross Hospital and Atomic-Bomb Survivors Hospital, Japan, 2.Div. Laboratory, Hiroshima Red-cross Hospital and Atomic-Bomb Survivors Hospital, Japan, 3.Div. Hematology, Itsukaichi Memorial Hospital, Japan)

Abstract password authentication.
Password is written on a program and abstract book.